METHODS FOR IMPROVED ENGRAFTMENT FOLLOWING STEM CELL TRANSPLANTATION
The present invention relates to methods repairing, regenerating, and reconstituting tissues by transplanting at least two stem cell populations, wherein the first and the second population of stem cells are introduced into a subject separated by a time interval of about 2 to about 24 hours. The stem cells can be derived from umbilical cord, mobilized peripheral blood, or bone marrow. The cells of at least the second population may be enriched for adult stem and progenitor cells. The methods of the invention are useful in accelerating hematopoeitic recovery in subjects following myeloablation or chemotherapy.
1 . A method of reconstituting blood tissue in a subject in need thereof, said method comprising introducing into said subject a first and a second population of cells, wherein said second population of cells is introduced between 2 and 24 hours after the first population of cells, and wherein at least the second population is capable of engraftment.
2 . The method of claim 1 , wherein said second population of cells is introduced about 4 hours after the first population.
3 . The method of claim 1 , wherein both the first and the second population of cells are capable of engraftment.
4 . The method of claim 1 , wherein the first and second populations of cells are derived from a source selected from the group consisting of umbilical cord blood, bone marrow, and mobilized peripheral blood.
5 . The method of claim 4 , wherein the first and second populations of cells are derived from the same source.
6 . The method of claim 4 , wherein the first and second populations of cells are derived from different sources.
7 . The method of claim 1 , wherein said subject is in need of hematopoietic reconstitution following bone marrow ablation.
8 . The method of claim 1 , wherein at least the second population of cells is enriched for adult stem and progenitor cells.
9 . The method of claim 8 , wherein the second population of cells is introduced about 4 hours after the first population.
10 . A method of restoring hematologic function following myeloablative treatment in a subject having cancer comprising introducing into said subject a first and a second population of cells, wherein said second population of cells is introduced between 2 and 24 hours after the first population of cells, and wherein at least the second population is capable of engraftment.
11 . The method of claim 10 , wherein at least the second population of cells is enriched for adult stem and progenitor cells.
12 . The method of claim 10 , wherein said subject is in need of treatment for sequelae related to cancer therapy.
13 . A method for potentiating engraftment of a stem cell population in a subject in need thereof comprising introducing into said subject a first and a second population of cells, wherein said second population of cells is introduced between 2 and 24 hours after the first population of cells, and wherein at least the second population is capable of engraftment.
14 . The method of claim 13 , wherein at least the second population of cells is enriched for adult stem and progenitor cells.
15 . The method of claim 13 , wherein the time to neutrophil engraftment in the subject is shortened compared to the time to neutrophil engraftment in a control subject.
16 . The method of claim 13 , wherein the time to platelet engraftment is shortened compared to the time to platelet engraftment in a control subject.
17 . A method of restoring hematologic function following myeloablative treatment in a subject having a genetic disorder comprising introducing into said subject a first and a second population of cells, wherein said second population of cells is introduced between 2 and 24 hours after the first population of cells, and wherein at least the second population is capable of engraftment.
18 . The method of claim 17 , wherein at least the second population of cells is enriched for adult stem and progenitor cells.
19 . A method of restoring bone marrow stem or progentitor cell activity following myeloablative treatment in a subject having cancer comprising introducing into said subject a first and a second population of cells, wherein said second population of cells is introduced between 2 and 24 hours after the first population of cells, wherein at least the second population is an enriched ALDH br stem cell population.
20 . A method of restoring bone marrow stem or progentitor cell activity following myeloablative treatment in a subject having a genetic disorder comprising introducing into said subject a first and a second population of cells, wherein said second population of cells is introduced between 2 and 24 hours after the first population of cells, wherein at least the second population is an enriched ALDH br stem cell population.